7 June 2017
Valneva, a fully integrated, commercial stage biotech company focused on developing innovative lifesaving vaccines, today announced that Thomas Lingelbach, President & Chief Executive Officer, will provide a corporate presentation at the Jefferies 2017 Global Healthcare Conference in New York on Thursday, June 8, 2017 at 10:30 AM EDT.
In addition to this presentation, Valneva’s CEO will be meeting investors present at the conference.
Valneva is committed to interact on a regular basis with the financial community. All corporate information on the Company, such as its financial statements or its corporate presentations, is available on the Company’s website in the “Investors & Media” section (http://www.valneva.com/en/investors-media/123).